Joseph R. Bertino Memorial Lecture Series
November 12, 2025
Rutgers Cancer Institute
Auditorium A & B, 4:00 - 5:00 PM
Followed by Reception
This event will celebrate the life of Dr. Joseph R. Bertino, former Interim Director and Chief Scientific Officer of Rutgers Cancer Institute, and examine clinical, laboratory and translational research in the areas of cancer and hematologic disorders. Details and a formal agenda to follow. We hope you will join us.
To support the Joseph R. Bertino Memorial Lecture Series, please visit raise.rutgersfoundation.org/event/bertino.
Lecture Title: "Drugging Ras: Up, Down, and Sideways”
Speaker: Jonathan Chernoff, MD, PhD
Cancer Center Director
Senior Vice President
Staney P. Reimann Chair in Oncology Research
Fox Chase Cancer Center
As Cancer Center Director at Fox Chase Cancer Center, Jonathan Chernoff works with Temple University Health System and Temple University peers to lead Fox Chase into the future of cancer care. With decades of research expertise, Chernoff has helped Fox Chase focus on the areas that best leverage the institution’s enhanced strengths in scientific development: translational research, precision medicine, epigenetics, signaling reprograming, immunotherapy, hematologic malignancies, and cancer disparities.
A molecular oncologist and board-certified medical oncologist, Chernoff joined Fox Chase in 1991. In addition to helping define the strategic direction for Fox Chase research, he has made fundamental contributions in his own laboratory, which focuses on factors that control cell growth and movement, including oncogenes and anticancer or tumor-suppressor genes. He currently holds the Stanley P. Reimann Chair in Oncology Research.
Previous Years
2024 Program
View the 2024 program with Yang-Yu Liu, PhD, Associate Professor, Harvard Medical School and Associate Scientist, Brigham and Women’s Hospital.
2023 Program
View the 2023 program with Arnold J. Levine, PhD, Professor Emeritus of Systems Biology, Institute for Advanced Study, who discussed the 'Exploration of the Genetic and Genomic Causes of Cancers of African or European Ancestry.'
2022 Program
View the inaugural 2022 program with speakers:
Frederick W. Alt, PhD ~ 'Anti-Cancer Drug Resistance, Gene Amplification & Beyond'
Charles A. Janeway Professor of Pediatrics Professor of Genetics, Harvard Medical School Investigator, Howard Hughes Medical Institute Director, Program in Cellular & Molecular Medicine, Boston Children’s Hospital
Bruce A. Chabner, MD ~ 'Travels with Joe Along the Folate Highway'
Allen Distinguished Investigator Clinical Director Emeritus, Massachusetts General Hospital
Carl H. June, MD ~ 'Engineered T-Cells as Cancer Therapy'
Director, Center for Cellular Immunotherapies Director, Parker Institute for Cancer Immunotherapy Richard W. Vague Professor in Immunotherapy Professor of Medicine, University of Pennsylvania